Exhibit 99.4

ASML — Summary IFRS Consolidated Income Statement ¹


	Three months ended,					Six months ended,
(in thousands EUR)	Jun 29, 2008		Jun 28, 2009			Jun 29, 2008			Jun 28, 2009


Net system sales		725,586		183,259			1,545,572			284,359
Net service and field option sales		118,571		93,341			217,793			175,866

Total net sales		844,157		276,600			1,763,365			460,225

Cost of sales		525,228		248,569			1,086,915			444,929

Gross profit on sales		318,929		28,031			676,450			15,296

Research and development costs, net of credits		87,066		82,512			169,789			160,536
Selling, general and administrative costs		55,331		38,917			113,027			80,885

Operating income (loss)		176,532		(93,398	)		393,634			(226,125	)

Interest income (charges)		4,973		(1,290	)		8,548			1,970

Income (loss) before income taxes		181,505		(94,688	)		402,182			(224,155	)

(Provision for) benefit from income taxes		28,986		13,433			(25,231	)		35,125

Net income (loss)		210,491		(81,255	)		376,951			(189,030	)

ASML — Summary IFRS Consolidated Statement of Financial Position ¹


(in thousands EUR)	Dec 31, 2008		Jun 28, 2009


ASSETS

Property, plant and equipment		550,921		600,485
Goodwill		139,626		142,901
Other intangible assets		289,530		330,421
Deferred tax assets		225,544		268,700
Finance receivables		31,030		20,609
Derivative financial instruments		53,206		33,375
Other assets		29,449		15,219

Total non-current assets		1,319,306		1,411,710

Inventories		999,150		926,080
Current tax assets		87,560		—
Derivative financial instruments		39,240		37,936
Finance receivables		6,225		52
Accounts receivable		463,273		213,532
Other assets		170,680		162,138
Cash and cash equivalents		1,109,184		1,092,660

Total current assets		2,875,312		2,432,398

Total assets		4,194,618		3,844,108

EQUITY AND LIABILITIES

Equity		2,188,743		1,925,064

Long-term debt		661,483		660,462
Derivative financial instruments		19,743		1,043
Deferred and other tax liabilities		260,360		263,623
Provisions		15,495		14,790
Accrued liabilities and other liabilities		50,293		44,576

Total non-current liabilities		1,007,374		984,494

Accounts payable		193,690		234,567
Accrued liabilities and other liabilities		732,043		652,413
Current tax liabilities		20,039		19,946
Derivative financial instruments		48,051		24,990
Provisions		4,678		2,634

Total current liabilities		998,501		934,550

Total equity and liabilities		4,194,618		3,844,108

ASML — Summary IFRS Consolidated Statement of Cash Flows ¹


	Three months ended,						Six months ended,
(in thousands EUR)	Jun 29, 2008			Jun 28, 2009			Jun 29, 2008			Jun 28, 2009


CASH FLOWS FROM OPERATING ACTIVITIES

Net income (loss)		210,491			(81,255	)		376,951			(189,030	)

Depreciation and amortization		44,723			38,737			89,941			102,381
Impairment charges		93			4,387			1,644			6,979
Loss on disposals of property, plant and equipment		1,311			8,699			2,414			11,338
Share-based payments		2,873			2,581			6,277			6,093
Allowance for doubtful debts		(647	)		1,177			(107	)		1,164
Allowance for obsolete inventory		11,790			43,897			32,556			66,032
Change in assets and liabilities		(91,605	)		90,395			(17,765	)		227,707

Net cash provided by operating activities		179,029			108,618			491,911			232,664

CASH FLOWS FROM INVESTING ACTIVITIES

Purchases of property, plant and equipment		(65,441	)		(43,336	)		(120,473	)		(87,240	)
Proceeds from sale of property, plant and equipment		—			—			—			1,200
Purchases of intangible assets		(43,083	)		(35,378	)		(88,609	)		(75,669	)

Net cash used in investing activities		(108,524	)		(78,714	)		(209,082	)		(161,709	)

CASH FLOWS FROM FINANCING ACTIVITIES

Purchase of shares in conjunction with share-based payment plans		—			—			(87,605	)		—
Net proceeds from issuance of shares and stock options		552			429			3,527			532
Dividend paid		(107,447	)		(86,486	)		(107,447	)		(86,486	)
Net proceeds from other long term debt		—			32			—			32
Redemption and / or repayment of debt		—			(1,745	)		—			(3,480	)

Net cash used in financing activities		(106,895	)		(87,770	)		(191,525	)		(89,402	)


Net cash flows		(36,390	)		(57,866	)		91,304			(18,447	)
Effect of changes in exchange rates on cash		144			(484	)		(2,042	)		1,923

Net increase (decrease) in cash & cash equivalents		(36,246	)		(58,350	)		89,262			(16,524	)

ASML — Quarterly Summary IFRS Consolidated Income Statement ¹


	Three months ended,
	Jun 29,		Sep 28,			Dec 31,			Mar 29,			Jun 28,
(in millions EUR)	2008		2008			2008			2009			2009


Net system sales		725.6		590.7			380.5			101.1			183.3
Net service and field option sales		118.6		105.8			113.3			82.5			93.3

Total net sales		844.2		696.5			493.8			183.6			276.6

Cost of sales		525.3		452.7			476.5			196.3			248.6

Gross profit (loss) on sales		318.9		243.8			17.3			(12.7	)		28.0

Research and development costs, net of credits		87.1		88.6			95.8			78.0			82.5
Selling, general and administrative costs		55.3		52.2			47.7			42.0			38.9

Operating income (loss)		176.5		103.0			(126.2	)		(132.7	)		(93.4	)

Interest income (charges)		5.0		6.6			2.8			3.2			(1.3	)

Income (loss) before income taxes		181.5		109.6			(123.4	)		(129.5	)		(94.7	)

(Provision for) benefit from income taxes		29.0		(27.0	)		40.8			21.7			13.4

Net income (loss)		210.5		82.6			(82.6	)		(107.8	)		(81.3	)

ASML — Quarterly Summary IFRS Consolidated Statement of Financial Position ¹


	Jun 29,		Sep 28,		Dec 31,		Mar 29,		Jun 28,
(in millions EUR)	2008		2008		2008		2009		2009


ASSETS

Property, plant and equipment		458.1		503.1		550.9		596.1		600.5
Goodwill		127.3		137.3		139.6		148.4		142.9
Other intangible assets		260.5		281.3		289.5		306.1		330.4
Deferred tax assets		238.4		228.6		225.6		244.6		268.7
Finance receivables		—		30.7		31.0		29.2		20.6
Derivative financial instruments		1.4		12.3		53.2		70.0		33.4
Other assets		32.0		32.6		29.5		14.2		15.2

Total non-current assets		1,117.7		1,225.9		1,319.3		1,408.6		1,411.7

Inventories		1,130.2		1,134.0		999.1		936.8		926.1
Current tax assets		—		—		87.6		—		—
Derivative financial instruments		46.6		21.0		39.2		33.6		37.9
Finance receivables		0.2		7.4		6.2		6.2		0.1
Accounts receivable		516.7		536.1		463.3		291.6		213.5
Other assets		185.9		210.6		170.7		186.0		162.1
Cash and cash equivalents		1,360.9		1,313.0		1,109.2		1,151.0		1,092.7

Total current assets		3,240.5		3,222.1		2,875.3		2,605.2		2,432.4

Total assets		4,358.2		4,448.0		4,194.6		4,013.8		3,844.1

EQUITY AND LIABILITIES

Equity		2,242.6		2,314.7		2,188.7		2,007.7		1,925.1

Long-term debt		585.6		591.0		661.5		671.5		660.5
Derivative financial instruments		11.2		0.9		19.7		1.6		1.0
Deferred and other tax liabilities		260.2		256.9		260.4		258.1		263.6
Provisions		—		—		15.5		16.9		14.8
Accrued liabilities and other liabilities		7.4		7.8		50.3		46.7		44.6

Total non-current liabilities		864.4		856.6		1,007.4		994.8		984.5

Accounts payable		267.2		271.0		193.7		165.2		234.6
Accrued liabilities and other liabilities		910.8		948.1		732.0		789.8		652.4
Current tax liabilities		50.8		42.4		20.0		11.2		19.9
Derivative financial instruments		22.4		15.2		48.1		40.6		25.0
Provisions		—		—		4.7		4.5		2.6

Total current liabilities		1,251.2		1,276.7		998.5		1,011.3		934.5

Total equity and liabilities		4,358.2		4,448.0		4,194.6		4,013.8		3,844.1

ASML — Quarterly Summary IFRS Consolidated Statement of Cash Flows ¹


	Three months ended,
	Jun 29,			Sep 28,			Dec 31,			Mar 29,			Jun 28,
(in millions EUR)	2008			2008			2008			2009			2009


CASH FLOWS FROM OPERATING ACTIVITIES

Net income (loss)		210.5			82.6			(82.6	)		(107.8	)		(81.3	)

Depreciation and amortization		44.7			50.1			57.2			63.6			38.7
Impairment charges		—			0.6			41.2			2.6			4.4
Loss on disposals of property, plant and equipment		1.3			1.4			0.4			2.6			8.7
Share-based payments		2.9			3.6			3.0			3.5			2.6
Allowance for doubtful debts		(0.6	)		(0.2	)		0.5			—			1.2
Allowance for obsolete inventory		11.8			21.3			85.8			22.1			43.9
Change in assets and liabilities		(91.6	)		(99.0	)		(215.3	)		137.4			90.4

Net cash provided by (used in) operating activities		179.0			60.4			(109.8	)		124.0			108.6

CASH FLOWS FROM INVESTING ACTIVITIES

Purchases of property, plant and equipment		(65.5	)		(68.3	)		(71.1	)		(43.9	)		(43.3	)
Proceeds from sale of property, plant and equipment		—			—			—			1.2			—
Purchases of intangible assets		(43.0	)		(41.4	)		(49.4	)		(40.3	)		(35.4	)

Net cash used in investing activities		(108.5	)		(109.7	)		(120.5	)		(83.0	)		(78.7	)

CASH FLOWS FROM FINANCING ACTIVITIES

Dividend paid		(107.4	)		(0.4	)		—			—			(86.5	)
Net proceeds from issuance of shares and stock options		0.5			1.4			6.5			0.1			0.4
Net proceeds from other long-term debt		—			—			19.9			—			0.1
Redemption and/or repayment of debt		—			(1.3	)		(1.1	)		(1.7	)		(1.7	)

Net cash provided by (used in) financing activities		(106.9	)		(0.3	)		25.3			(1.6	)		(87.7	)


Net cash flows		(36.4	)		(49.6	)		(205.0	)		39.4			(57.8	)

Effect of changes in exchange rates on cash		0.2			1.7			1.2			2.4			(0.5	)

Net increase (decrease) in cash & cash equivalents		(36.2	)		(47.9	)		(203.8	)		41.8			(58.3	)

ASML — Notes to the Summary IFRS Consolidated Financial Statements

Basis of Presentation

ASML has prepared the accompanying summary consolidated financial statements in accordance with International Financial Reporting Standards (“IFRS”) as adopted by the EU — accounting principles generally accepted in the Netherlands for companies quoted on Euronext Amsterdam. Further disclosures, as required under IFRS in annual reports and interim reporting (IAS 34), are not included. The accompanying consolidated financial statements are stated in thousands of euros (‘EUR’), except otherwise indicated.

For internal and external reporting purposes, ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). U.S. GAAP is ASML’s primary accounting standard for the Company’s setting of financial and operational performance targets.

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.

Use of estimates

The preparation of ASML’s consolidated financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.

Recognition of revenues

In general, ASML recognizes the revenue from the sale of a system upon shipment and the revenue from the installation of a system upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in our clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue is recognized, only after all specifications are met and customer sign-off is received or waived. Although each system’s performance is re-tested upon installation at the customer’s site, we have never failed to successfully complete installation of a system at a customer’s premises.

A portion of our revenue is derived from contractual arrangements with our customers that have multiple deliverables, such as installation and training services, prepaid service contracts and prepaid extended optic warranty contracts. The revenue relating to the undelivered elements of the arrangements is deferred until delivery of these elements. Revenue from installation and training services is recognized when the services are completed. Revenue from prepaid service contracts and prepaid extended optic warranty contracts is recognized over the term of the contract.

Foreign currency risk management

The Company uses the euro as its invoicing currency in order to limit the exposure to foreign currency movements. Exceptions may occur on a customer by customer basis. To the extent that invoicing is done in a currency other than the euro, the Company is exposed to foreign currency risk.

It is the Company’s policy to hedge material transaction exposures, such as sales transactions, forecasted purchase transactions and accounts receivable/accounts payable. The Company hedges these exposures through the use of foreign exchange options and forward contracts. The use of a mix of foreign exchange options and forward contracts is aimed at reflecting the likelihood of the transactions occurring.

It is the Company’s policy to hedge material remeasurement exposures. These net exposures from certain monetary assets and liabilities in non-functional currencies are hedged with forward contracts.

As of June 28, 2009 EUR 36.9 million loss of other comprehensive income, net of taxes, represents the total anticipated loss to be charged to net sales, and EUR 1.2 million gain represents the total anticipated gain to be released to cost of sales when the forecasted revenue and purchase transactions occur.

Statutory Interim Report

While the financial figures included in these consolidated financial statements have been computed in accordance with International Financial Reporting Standards (IFRSs) applicable to interim periods, this announcement does not contain sufficient information to constitute an interim financial report as that term is defined in IFRSs. The Board of Management expects to publish the Statutory Interim Financial Report that complies with IAS 34 on July 24, 2009.

ASML — Reconciliation U.S. GAAP — IFRS¹

Net income


	Three months ended,						Six months ended,
(in thousands EUR)	Jun 29, 2008			Jun 28, 2009			Jun 29, 2008			Jun 28, 2009

Net income (loss) under U.S. GAAP		191,977			(103,953	)		337,100			(221,144	)
Share-based payments (see Note 1)		245			1,396			(518	)		897
Capitalization of development costs (see Note 2)		18,649			21,760			40,330			33,275
Income taxes (see Note 3)		(380	)		(458	)		39			(2,058	)

Net income (loss) under IFRS		210,491			(81,255	)		376,951			(189,030	)

Shareholders’ equity


	Jun 29,			Sep 28,			Dec 31,			Mar 29,			Jun 28,
(in thousands EUR)	2008			2008			2008			2009			2009

Shareholders’ equity under U.S. GAAP		2,060,575			2,122,848			1,988,769			1,795,951			1,691,240
Share-based payments (see Note 1)		(3,266	)		(7,904	)		(6,537	)		(7,088	)		(4,918	)
Capitalization of development costs (see Note 2)		176,818			193,780			201,717			215,452			235,945
Income taxes (see Note 3)		8,478			5,969			4,794			3,361			2,797

Shareholders’ equity under IFRS		2,242,605			2,314,693			2,188,743			2,007,676			1,925,064

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Share-based Payments

Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options and stock granted to its employees after November 7, 2002. Under IFRSs, a deferred tax asset is computed on the basis of the tax deduction for the share-based payments every period under the applicable tax law and is recognized to the extent it is probable that future taxable profit will be available against which these deductible temporary differences will be utilized. Therefore, changes in the Company’s share price do affect the deferred tax asset at period-end and result in adjustments to the deferred tax asset.

As of January 1, 2006, ASML applies SFAS No. 123(R) “Share-Based Payment” which is a revision of SFAS No.123. SFAS 123(R) requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments. SFAS 123(R)’s general principle is that a deferred tax asset is established as the Company recognizes compensation costs

for commercial purposes for awards that are expected to result in a tax deduction under existing tax law. Under U.S. GAAP, the deferred tax recorded on share-based compensation is computed on the basis of the expense recognized in the financial statements. Therefore, changes in the Company’s share price do not affect the deferred tax asset recorded in the Company’s financial statements.

Note 2 Capitalization of development costs

Under IFRS, ASML applies IAS 38, “Intangible Assets”. In accordance with IAS 38, capitalized development expenditures are amortized over the expected useful life of the related product generally ranging between one and three years. Amortization starts when the developed product is ready for volume production. In 2008, we recognized an impairment charge for an amount of EUR 18.3 million.

Under U.S. GAAP, ASML applies SFAS No. 2, “Accounting for Research and Development Costs”. In accordance with SFAS No. 2, ASML charges costs relating to research and development to operating expense as incurred.

Note 3 Income taxes

Under IFRS, ASML applies IAS 12, “Income Taxes” beginning from January 1, 2005. In accordance with IAS 12 unrealized net income resulting from intercompany transactions that are eliminated from the carrying amount of assets on consolidation, give rise to a temporary difference for which deferred taxes must be recognized on consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.

Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets on consolidation, give rise to a temporary difference for which prepaid taxes must be recognized on consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller’s tax jurisdiction.

“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average sales price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, credit market deterioration on consumer confidence which could affect our customers, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.


¹		All quarterly information in this press release is unaudited.